Search research articles
Contact Us
Filters
Showing results (51-60 of 85) with videos related to
Page
of 9
Sort By:
Plos One
|
September 17, 2020
Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study
Mohammad Aladwani, Artitaya Lophatananon, Fredie Robinson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2016
Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer
Shaista Hafeez, Karole Warren-Oseni, Helen A McNair, et al.
Clinical and Translational Radiation Oncology
|
February 20, 2020
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial
Julia Murray, Sarah Gulliford, Clare Griffin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 27, 2019
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer
Julia Murray, Clare Griffin, Sarah Gulliford, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 2019
Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial
Julia R Murray, Alison C Tree, Emma J Alexander, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 28, 2024
Bladder Tumor-Focused Adaptive Radiation Therapy: Clinical Outcomes of a Phase I Dose Escalation Study
Shaista Hafeez, Karole Warren-Oseni, Kelly Jones, et al.
The British Journal of Nutrition
|
January 20, 2010
Dietary fat and early-onset prostate cancer risk
Artitaya Lophatananon, Jane Archer, Douglas Easton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 23, 2008
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
Gerhardt Attard, Alison H M Reid, Timothy A Yap, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 12, 2018
Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)
David Dearnaley, Clare L Griffin, Rebecca Lewis, et al.
JAMA Oncology
|
February 18, 2021
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
Adnan Ali, Alex Hoyle, Áine M Haran, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 85) with videos related to
Sort By:
Page
of 9
Plos One
|
September 17, 2020
Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study
Mohammad Aladwani, Artitaya Lophatananon, Fredie Robinson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2016
Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer
Shaista Hafeez, Karole Warren-Oseni, Helen A McNair, et al.
Clinical and Translational Radiation Oncology
|
February 20, 2020
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial
Julia Murray, Sarah Gulliford, Clare Griffin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 27, 2019
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer
Julia Murray, Clare Griffin, Sarah Gulliford, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 2019
Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial
Julia R Murray, Alison C Tree, Emma J Alexander, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 28, 2024
Bladder Tumor-Focused Adaptive Radiation Therapy: Clinical Outcomes of a Phase I Dose Escalation Study
Shaista Hafeez, Karole Warren-Oseni, Kelly Jones, et al.
The British Journal of Nutrition
|
January 20, 2010
Dietary fat and early-onset prostate cancer risk
Artitaya Lophatananon, Jane Archer, Douglas Easton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 23, 2008
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
Gerhardt Attard, Alison H M Reid, Timothy A Yap, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 12, 2018
Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)
David Dearnaley, Clare L Griffin, Rebecca Lewis, et al.
JAMA Oncology
|
February 18, 2021
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
Adnan Ali, Alex Hoyle, Áine M Haran, et al.
Page
of 9